Suven Life Sciences has informed that pursuant to Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, a Meeting of the Board of Directors of the Company will be held on Friday, the 05th June, 2020 at 11:30 am at the Registered Office of the Company at SDE Serene Chambers, 6th Floor, Road No 5, Banjara Hills, Hyderabad-500034, to consider, among other things, and take on record the Audited Financial Results (Standalone and Consolidated) of the Company under Ind AS for the fourth quarter and year ended 31st March, 2020 and related matters. The Trading Window for dealing in the securities of the company is already closed from 01st April, 2020 as per PIT Code of the Company. Trading window will be opened from 8th June, 2020.
The above information is a part of company’s filings submitted to BSE.
